Serum fibroblast growth factor 21 is a superior biomarker to other adipokines in predicting incident diabetes

Summary Objective Fibroblast growth factor 21 (FGF21) improves glucose and lipid metabolism, but high circulating levels are found in type 2 diabetes, suggesting FGF21 resistance. Serum FGF21 predicts incident diabetes, but its performance compared to established and emerging predictors is not known...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Clinical endocrinology (Oxford) 2017-01, Vol.86 (1), p.37-43
Hauptverfasser: Woo, Yu Cho, Lee, Chi Ho, Fong, Carol H.Y., Xu, Aimin, Tso, Annette W.K., Cheung, Bernard M.Y., Lam, Karen S.L.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!